Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Curr Oncol. 2022 Aug 16;29(8):5800-5809. doi: 10.3390/curroncol29080457.
(1) Background: The reasons for changes in the inflammatory markers of patients with surgically resected hepatocellular carcinoma are unclear. We aimed to investigate the association of an inflammatory status with the prognosis of patients with hepatocellular carcinoma, who underwent surgical resection. (2) Methods: We retrospectively enrolled 91 patients with Child A hepatocellular carcinoma, who had received surgical resection, to explore the influence of preoperative inflammatory markers and postoperative changes on the prognosis. (3) Results: The platelet-to-lymphocyte ratio (PLR) and its alteration were independent prognostic factors. Patients with a low PLR had a significantly better recurrence-free survival (RFS) than those with a high PLR (1-year RFS of 88.5% versus 50.0%; 3-year RFS of 62.1% versus 25.0%, = 0.038). The patients with a low PLR showed a significantly better overall survival (OS) than those with a high PLR (1-year OS of 98.9% versus 75.0%; 3-year OS of 78.2% versus 25.0%, = 0.005). The patients whose PLR had increased at 6 months after operation showed a worse OS than patients whose PLR had decreased (1-year OS of 96.3% versus 98.4%; 3-year OS of 63.0% versus 79.7%, = 0.048). However, neither the neutrophil-to-lymphocyte ratio nor Onodera's prognostic nutritional index had any prognostic significance. (4) Conclusions: The PLR and its alteration are significant prognostic factors for the RFS and OS of patients with Child A hepatocellular carcinoma who had received curative surgery.
(1) 背景:手术切除的肝细胞癌患者炎症标志物变化的原因尚不清楚。我们旨在研究炎症状态与接受手术切除的肝细胞癌患者预后的关系。
(2) 方法:我们回顾性纳入了 91 例接受手术切除的 Child A 肝癌患者,以探讨术前炎症标志物及其术后变化对预后的影响。
(3) 结果:血小板与淋巴细胞比值(PLR)及其变化是独立的预后因素。低 PLR 患者的无复发生存率(RFS)显著优于高 PLR 患者(1 年 RFS 为 88.5%比 50.0%;3 年 RFS 为 62.1%比 25.0%,= 0.038)。低 PLR 患者的总生存率(OS)显著优于高 PLR 患者(1 年 OS 为 98.9%比 75.0%;3 年 OS 为 78.2%比 25.0%,= 0.005)。术后 6 个月 PLR 升高的患者 OS 差于 PLR 降低的患者(1 年 OS 为 96.3%比 98.4%;3 年 OS 为 63.0%比 79.7%,= 0.048)。然而,中性粒细胞与淋巴细胞比值和 Onodera 的预后营养指数均无预后意义。
(4) 结论:PLR 及其变化是接受根治性手术的 Child A 肝癌患者 RFS 和 OS 的重要预后因素。